Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 29, 2019 05:14 ET | Source: Coloplast A/S

Aktietilbagekøb uge 17/2019

Selskabsmeddelelse29. april 2019 Coloplast – transaktioner i henhold til aktietilbagekøbsprogram Som meddelt i Selskabsmeddelelse nr. 2/2019 har Coloplast iværksat anden del af...
April 29, 2019 05:14 ET | Source: Coloplast A/S

Share buy-back week 17/2019

Announcement 29 April 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the...
April 23, 2019 05:33 ET | Source: Coloplast A/S

Aktietilbagekøb uge 16/2019

Selskabsmeddelelse23. april 2019 Coloplast – transaktioner i henhold til aktietilbagekøbsprogram Som meddelt i Selskabsmeddelelse nr. 2/2019 har Coloplast iværksat anden del af...
April 23, 2019 05:33 ET | Source: Coloplast A/S

Share buy-back week 16/2019

Announcement 23 April 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the...
April 17, 2019 04:32 ET | Source: Coloplast A/S

Correction: Selskabsmeddelelse nr. 03/2019 - Coloplast reagerer på FDA’s beslutning om at fjerne kirurgiske transvaginale net som behandlingsform mod nedsunken underliv

Selskabsmeddelelse nr. 03/201917. april 2019 Coloplast reagerer på FDA’s beslutning om at fjerne kirurgiske transvaginale net som behandlingsform mod nedsunken underliv Coloplast blev i går...
April 17, 2019 04:32 ET | Source: Coloplast A/S

Correction: Announcement no. 3/2019 - Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse

Announcement no. 3/201917 April 2019 Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse Coloplast was informed yesterday...
April 17, 2019 04:01 ET | Source: Coloplast A/S

Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse

Coloplast was informed yesterday by the FDA that the PMA for Restorelle DirectFix Anterior is not approved and the company must cease marketing and distribution immediately. As a result, FDA...
April 17, 2019 04:01 ET | Source: Coloplast A/S

Coloplast reagerer på FDA’s beslutning om at fjerne kirurgiske transvaginale net som behandlingsform mod nedsunken underliv

Coloplast blev i går informeret om, at den amerikanske føderale fødevare- og lægemiddelmyndighed FDA (US Food and Drug Administration) ikke har godkendt Restorelle DirectFix Anterior, og at selskabet...
April 17, 2019 03:59 ET | Source: Coloplast A/S

Announcement no. 3/2019 - Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse

Announcement no. 3/201917 April 2019 Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse Coloplast was informed yesterday by the...
April 17, 2019 03:59 ET | Source: Coloplast A/S

Selskabsmeddelelse nr. 03/2019 - Coloplast reagerer på FDA’s beslutning om at fjerne kirurgiske transvaginale net som behandlingsform mod nedsunken underliv

Selskabsmeddelelse nr. 03/201917. april 2019 Coloplast reagerer på FDA’s beslutning om at fjerne kirurgiske transvaginale net som behandlingsform mod nedsunken underliv Coloplast blev i går...